Cinemark Holdings, Inc. research snapshot
CNK AI stock analysis reads Cinemark Holdings as a movie exhibition business that just delivered the strongest quarter in its history: worldwide revenue above $1 billion for the first time, record Adjusted EBITDA, record admissions and concession revenue, and its biggest domestic weekend box office ever. At the August 4, 2026 data cutoff, CNK traded near $37.71 with a verified market capitalization of $4.33 billion, up roughly 46% over the trailing year and near its 52-week high of $38.98. This page uses scenario ranges and source checks, not a certain stock price prediction, and is for informational use only.
Current price
$37.71
Market cap
$4.33 billion
AI score
74 / 100
Rating
Recovery momentum play: record Q2 2026 revenue and market share gains vs. leverage, valuation, and slate-cycle risk
Trend status
At a new 52-week high near $38.98 after the strongest quarter in company history
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Cinemark operates one of the largest movie theatre chains in the Americas with theatres in the United States and Latin America. Revenue comes from admissions, concessions, screen advertising, premium formats, and merchandise. Q2 2026 produced the first-ever quarter above $1 billion in worldwide revenue, with over 60 million moviegoers. The business is asset-heavy and cyclical. | High for Q2 data |
| Moat | Moat is local and practical: prime real estate locations, long-term lease control, premium large-format screens such as XD, IMAX, and ScreenX, a Movie Club loyalty program that surpassed 1.5 million members, 40 million addressable customers, and scale purchasing power for concessions. Cinemark is gaining domestic and international market share. | Medium |
| Management | CEO Sean Gamble and CFO Melissa Thomas led a record quarter with balanced capital allocation: dividend and buybacks, debt reduction, premium format investment, and merchandise expansion. Management reports improving theatrical window exclusivity and disciplined cost control across domestic and international segments. | Medium |
| Financial trend | Revenue recovered from $1.51 billion in 2021 to $3.115 billion in FY2025. Net income turned positive in 2023, declined from $309.7 million in FY2024 to $138.2 million in FY2025, then surged in Q2 2026 to $139 million with record Adjusted EBITDA of $294 million at a 27.1% margin. TTM net income is $214.4 million. | High |
| Valuation | At $37.71, CNK trades at about 20.4x trailing EPS of $1.84, 15.8x forward earnings, 1.31x revenue, 8.47x book value, and 14.1x free cash flow. The forward multiple still implies that the record 2026 recovery must be sustained, leaving limited headroom against the $39.36 analyst consensus target. | Medium-high |
| Technical trend | CNK is in a strong uptrend, up roughly 46% over 52 weeks and holding above its 50-day moving average of $31.56 and 200-day moving average of $27.77. The RSI near 78.9 signals overbought conditions after the move to the 52-week high of $38.98. | High for data |
| Risk level | Elevated but improved. Key risks include film slate concentration, theatrical window compression, consumer discretionary sensitivity, energy cost inflation in Texas, total debt of $2.97 billion, a debt-to-equity ratio near 5.88, and a moderate Altman Z-Score of 1.51. Short interest of 7.43% of shares out adds volatility potential. | Medium-high |
| AI confidence | High for market cap, price, share count, FY2025 and Q2 2026 filings, and common ratios. Medium for forward scenarios and technical chart levels due to film slate unpredictability. | High data confidence |
| Investment certainty | Medium. The recovery thesis is now partially proven, but the stock trades at a 52-week high near consensus targets with elevated leverage and an overbought RSI. The page frames scenarios and monitoring rules, not a buy or sell instruction. | Medium |
CNK AI stock forecast
The CNK AI stock forecast uses scenario math around the $37.71 quote, TTM EPS of $1.84, FY2026E adjusted EPS near $2.32, and FY2027E adjusted EPS near $2.62. The framework produces a bearish area near $24 to $29, a base area near $33 to $40, and a bullish area near $43 to $49, reflecting both the record recovery momentum and the limits of current valuation.
$43 to $49
More likely if the 2026-2027 slate, including Avengers: Doomsday and a strong 2027 lineup, sustains box office momentum, Cinemark holds market share gains and margins, and the market assigns a 17x to 18x multiple to FY2027E earnings near $2.62 or better.
$33 to $40
More likely if box office normalizes after the record first half, the company delivers FY2026E adjusted EPS near the $2.32 consensus, and the earnings multiple holds in the 14x to 16x range. This aligns with the $39.36 average analyst price target.
$24 to $29
More likely if the box office cycle turns down, theatrical exclusivity shrinks again, electricity or labor costs pressure margins, or consumer spending weakens, pulling earnings back toward the TTM $1.84 level and compressing the multiple to 13x to 14x.
CNK AI technical analysis
CNK AI technical analysis shows a stock in a strong uptrend that reached a new 52-week high of $38.98 on August 3, 2026, after record Q2 earnings and the biggest domestic weekend box office in company history. As of the data cutoff, the stock trades above its 50-day and 200-day moving averages with an overbought RSI near 78.9.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $37.71 | Quote snapshots around the August 4, 2026 cutoff placed CNK near $37.71 after a 3% gain on August 3, 2026. |
| Near support | $34.00 to $35.00 | Recent consolidation levels and the zone of the B. Riley and Wells Fargo price targets. A pullback here would be the first test of the trend. |
| Key support | $31.56 | The 50-day moving average is the near-term trend line. A decisive close below it would signal a loss of short-term momentum. |
| Major support | $27.77 | The 200-day moving average marks the medium-term trend. Losing this level would weaken the recovery structure established since the 52-week low. |
| Near resistance | $38.98 | The 52-week high set on August 3, 2026. A sustained close above it with volume would confirm a breakout toward the high-end analyst targets. |
| Major resistance | $39.36 to $43.00 | The consensus price target of $39.36 and the highest individual target of $43 form the upper resistance band. |
| Momentum | RSI 78.9, overbought | The Relative Strength Index near 78.9 signals overbought conditions after the strong run, increasing the chance of a consolidation or pullback. |
| Short interest | 7.43% of shares out | About 8.53 million shares are short, roughly 8.36% of float with 3.77 days to cover. Elevated short interest can add volatility and squeeze potential on strong catalysts. |
| Recent performance | +46% 52-week, above 50-day and 200-day averages | The stock is above both key moving averages with strong momentum, but the overbought RSI suggests stretched positioning near resistance. |
| Invalidation | Close below $34.00 | A decisive close below the $34 to $35 support zone would weaken the short-term uptrend; a break below $31.56 would signal a broader pullback. |
CNK AI trading strategy
The CNK AI trading strategy is a rules-based research framework for monitoring a recovering movie exhibition stock with leverage and slate-cycle risk. It is not personal advice and should be paired with fresh chart data, quarterly box office trends, upcoming film slate, debt metrics, and a defined invalidation level.
Watch for CNK to hold above the $38.98 52-week high on above-average volume, supported by continued box office strength from titles such as Avengers: Doomsday and the strong 2027 slate. A sustained move toward $43 would require confirmation of margin stability, market share gains, and debt reduction progress.
A close back below $34 or a failure to hold above $39 after an earnings or box office catalyst should invalidate the breakout setup.
If CNK pulls back toward the $34 to $35 zone or the 50-day moving average near $31.56 without a negative earnings revision, compare the risk-reward with upcoming film slate quality, industry box office data, energy costs, and the debt maturity schedule before assuming support holds.
Avoid averaging down without a strict maximum loss rule because exhibition stocks can gap on film slate news, streaming announcements, or box office misses.
Track quarterly box office revenue trends, attendance, average ticket price, concession per-patron, market share vs. the industry, Latin America performance, debt paydown, interest coverage, free cash flow, and dividend and buyback coverage.
Reduce position confidence if box office growth decelerates, margins compress on energy or labor costs, the theatrical window shrinks, or the debt-to-equity ratio and interest coverage deteriorate.
Investment research summary
Cinemark sells movie tickets, popcorn, soda, and merchandise in purpose-built theatres with premium large-format screens. Customers pay for the theatrical experience, but the same content is increasingly available on streaming platforms at home, which is why box office strength depends heavily on the film slate.
The moat is local rather than global. Prime theatre locations, long-term leases, XD, IMAX, and ScreenX premium screens, a Movie Club loyalty program above 1.5 million members, and scale in Latin America create barriers, but no single factor prevents a consumer from waiting for streaming.
The thesis fails if the film slate cycle turns down, theatrical exclusivity is compressed again, a recession cuts discretionary spending, electricity or labor costs pressure margins, or debt service consumes cash flow during a box office downturn.
Management should be judged by whether record Q2 2026 results translate into sustainable market share gains, margin stability, debt reduction, premium format ROI, and balanced capital allocation between growth and shareholder returns.
Movie exhibition is in a genuine recovery cycle: 2026 delivered record domestic openings such as Spider-Man: Brand New Day, expanding 45-day theatrical windows, and creator-led content that brings younger audiences back. The industry still faces secular streaming pressure, but the near-term trend is favorable.
At roughly 20.4x trailing EPS and 15.8x forward EPS, the stock prices in a continued recovery. Margin of safety is limited after the 46% 52-week run because the current price is close to the $39.36 consensus target and the record results are already widely known.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CNK price | $37.71 | StockAnalysis.com real-time quote snapshot | August 3, 2026 |
| Market capitalization | $4.33 billion, verified as $37.71 x 114.71 million shares | StockAnalysis.com quote and share count cross-check | August 3, 2026 |
| Q2 2026 results | Revenue $1.09B, net income $139M, record Adjusted EBITDA $294M at 27.1% margin | Cinemark Q2 2026 earnings release and earnings call via StockAnalysis.com and Deadline | July 30, 2026 |
| FY2025 revenue and net income | Revenue $3.115 billion, net income $138.2 million, EPS $1.04 | Cinemark FY2025 Form 10-K via StockAnalysis.com | July 30, 2026 |
| TTM financials | Revenue $3.36 billion, net income $214.4 million, EPS $1.84, EBITDA $641.6 million | StockAnalysis.com TTM data as of June 30, 2026 | August 3, 2026 |
| Cash and debt | Cash $507.6 million, total debt $2.97 billion, net debt $2.46 billion, debt-to-equity 5.88 | StockAnalysis.com balance sheet and ratios | August 3, 2026 |
| Free cash flow | TTM free cash flow $313 million, operating cash flow $579 million | StockAnalysis.com cash flow statement | August 3, 2026 |
| Dividend | $0.36 per share annually, 0.96% yield | StockAnalysis.com and Google Finance dividend data | August 3, 2026 |
| Analyst consensus | 11 analysts, consensus Buy, average target $39.36, range $33 to $43 | StockAnalysis.com analyst forecast | August 3, 2026 |
| Valuation snapshot | PE TTM 20.42, Forward PE 15.82, PS 1.31, PB 8.47, EV/EBITDA 10.71 | StockAnalysis.com valuation ratios | August 3, 2026 |
| Record weekend | Spider-Man: Brand New Day delivered the biggest domestic weekend box office in Cinemark history | Cinemark press release via StockAnalysis.com and Deadline | August 3, 2026 |
This page is an informational research tool only and is not investment advice, financial advice, or a recommendation to buy or sell CNK stock. Forecast scenarios are based on available public data, technical snapshots, and stated assumptions as of the data cutoff date and may be wrong. Always verify current filings, prices, risks, and personal suitability before making financial decisions.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
